Filing Details
- Accession Number:
- 0001555280-22-000233
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-09 16:11:45
- Reporting Period:
- 2022-08-05
- Accepted Time:
- 2022-08-09 16:11:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1555280 | Zoetis Inc. | ZTS | Pharmaceutical Preparations (2834) | 460696167 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1900620 | J Robert Polzer | C/O Zoetis Inc. 10 Sylvan Way Parsippany NJ 07054 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-05 | 1,721 | $87.51 | 3,057 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-08-05 | 1,120 | $171.77 | 1,937 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2022-08-05 | 1,721 | $0.00 | 1,721 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,691 | No | 4 | M | Direct |
Footnotes
- Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
- 1,721 options granted February 12, 2019 at an exercise price of $87.51 per option.
- Each option vests on the third anniversary of the date of grant.
- Each option expires on the tenth anniversary of the date of grant.
- 1,179 options granted February 11, 2020 at an exercise price of $144.03 per option; 1,057 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,455 options granted February 8, 2022 at an exercise price of $201.30 per option.